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S U M M A R Y
Background: Enteroviruses are seasonally prevalent each year in Southeast Asia. Elevated C-reactive
protein (CRP) levels have been noted in minor populations of patients, and antibiotics may be prescribed
under the impression of a suspected bacterial infection. This prescription might be inappropriate,
resulting in further bacterial resistance and medical expense. The aim of this study was to delineate how
effective antibiotics are for children suffering from enterovirus infection complicated with a high CRP
level.
Methods: The medical records of children hospitalized between January 2008 and December 2012 with
herpangina or hand, foot and mouth disease were reviewed retrospectively. The children enrolled were
divided into three groups, A, B, and C, by CRP level, which were <40, 40–80, and 80 mg/l, respectively. A
case–control study of group C divided into subgroups according to the prescription of antibiotics for at
least 24 h during the admission was conducted for further analysis.
Results: A total 3566 cases were identiﬁed; 214 were in group C and 71.0% of them received a
prescription for antibiotics. There was a linear trend between a relatively higher CRP level and a higher
proportion of antibiotics prescribed in the three groups (p = 0.001). In the case–control study, there were
no signiﬁcant differences in age, sex, mean CRP, or febrile days. However, a relatively longer stay of
hospitalization was recorded in the subgroup with an antibiotic prescription (p = 0.020).
Conclusions: The present study indicated that antibiotics might not be beneﬁcial in treating these
patients, even those with a high CRP level. Clinicians should be more prudent in antibiotic use when no
obvious evidence of bacterial infection is found.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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There is a high prevalence and morbidity of diseases caused by
enterovirus and coxsackievirus every year in Taiwan and Southeast
Asia.1–5 They can be diagnosed easily by their clinical presentations
of herpangina and hand, foot and mouth disease (HFMD). Most
patients have a self-limiting illness that resolves within a few days
without active intervention. A higher incidence and a possible* Corresponding author. Tel.: +886 7 7317123; fax: +886 7 7338009.
E-mail address: lee900@cgmh.org.tw (C.-H. Lee).
http://dx.doi.org/10.1016/j.ijid.2014.04.010
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).association with neurological sequelae and death have been shown
in a few cases with laboratory risk factors such as a high leukocyte
count and hyperglycemia. Previous studies have mainly focused on
serious complications.3 However in a literature review, approxi-
mately 6% of uncomplicated cases were noted to have elevated C-
reactive protein (CRP >80 mg/l).1,6 The implication of the CRP level
and the subsequent indication for antibiotics in these patients have
rarely been discussed.
CRP is produced by hepatocytes and is elevated at around 12 h
after a viral or bacterial infection. It is a very convenient and readily
available tool in clinical practice for infectious diseases, although
the cut-off level is not always reliable.7 It rises in response to bothciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Figure 1. The proportion of antibiotic prescriptions is illustrated in groups A (8.7%),
B (22.9%), and C (71.0%) according to the CRP level (<40, 40–80, and 80 mg/l,
respectively). The black column shows the number of episodes with an antibiotic
prescription in each group (A 236, B 149, and C 152); the white column shows the
number of episodes without an antibiotic prescription in each group (A 2465, B 502,
and C 62).
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in serious bacterial infections than in nearly all viral infections.6,8–
11 Clinicians may distinguish those children who have a serious
bacterial infection and who may beneﬁt from antibiotics by a
higher CRP level.
Therefore, a high CRP level in these cases remains a challenge
for pediatricians.12 Both doctors and parents are aware of the
potential beneﬁts of antibiotics for some patients and the potential
risks of not treating a life-threatening infection in a small minority.
Therefore, there is a relatively high motivation to prescribe
antibiotics, despite the costs, adverse effects, and increasing
potential antibiotic resistance resulting from this practice.
The present study had two speciﬁc aims. The ﬁrst was to
determine whether a higher CRP level in patients was associated
with a higher proportion of antibiotic prescriptions. The second
was to evaluate the potential beneﬁts of antibiotics for herpangina
or HFMD in those infants and children with a high CRP level
(80 mg/l).
2. Materials and methods
2.1. Study population and deﬁnitions
We identiﬁed infants and children hospitalized with herpan-
gina (074.0) or HFMD (074.3) by International Classiﬁcation of
Diseases Ninth Revision (ICD-9) code from our hospital database.
Medical information including antibiotic prescriptions and labo-
ratory data including serum CRP level and total white blood cell
(WBC) count during the hospitalization were collected and
analyzed. The laboratory data in this study were obtained at the
time of the patient’s ﬁrst clinical evaluation. Initially, in accordance
with previous studies,1,6 we divided the patients into three groups
by CRP level: A <40 mg/l, B 40–80 mg/l, and C 80 mg/l.
Patients enrolled in group C met the following criteria: (1) chief
complaints of fever with or without a poor appetite; (2) all had
both an initial impression and ﬁnal diagnosis associated with
herpangina or HFMD during this hospitalization; (3) all had a high
CRP level, deﬁned as no less than 80 mg/l (80 mg/l); and (4) none
had suffered from herpangina or HFMD in the 2 weeks prior to this
hospitalization. All cases had to fulﬁll these criteria. Institutional
approval to carry out this study was received. Ethics review board
approval was not required for this retrospective analysis.
The medical records of the cases were reviewed retrospectively
for demographic data, underlying diseases, clinical manifestations,
laboratory data, clinical outcome, and antibiotic therapy. Antibi-
otic therapy was deﬁned as a prescription of antibacterial agents
for more than 24 h during the admission. In the present study,
septic workup for urinary tract infection included all urinalysis and
urine culture. All patient urine specimens were collected by sterile
plastic bag or midstream urine collection. If there was neither
obvious pyuria (WBC >15  106/l), as assessed by hemocytometer
with an enhanced urinalysis, nor a single uropathogenic organism
on urine culture (>105 CFU/ml), this was recorded as a negative
result of urine examination for the septic workup.
2.2. Analysis of the beneﬁts of antibiotics by case–control study of
group C
We conducted a case–control study to further analyze the
effectiveness of antibiotics in our enrolled patients with high CRP
levels (group C). The case group comprised those who were given
antibiotic therapy for more than 24 h. The control group comprised
those cases who did not receive antibiotic therapy. In general, fever
is an objective symptom for the evaluation of infectious diseases.
For the analysis of the potential beneﬁts of antibiotics, we recorded
the duration of hospitalization and the patient’s clinical courserelated to fever, including the number of febrile days before and
after admission.
2.3. Statistical analysis
SPSS for Windows (version 17.0; SPSS Inc., Chicago, IL, USA) was
used for the data analysis. Descriptive statistics were performed,
with continuous variables summarized as the median and range,
and categorical variables summarized as the frequency and
proportion. The Chi-square test or Fisher’s exact test, or a non-
parametric test was used to assess differences between two
groups. The prevalence of the samples was compared with the
Chi-square test for linear trend. Statistical signiﬁcance was set at
p < 0.05.
3. Results
This retrospective cross-sectional study was conducted at
Kaohsiung Chang Gung Memorial Hospital, a medical center with
170 pediatric ward beds and 53 intensive care unit beds, providing
primary and tertiary care for infants and children in southern
Taiwan. The annual emergency department census in this hospital
is approximately 55 000 visits. The clinical microbiology laborato-
ry and medical records center databases were reviewed in order to
identify patients with enterovirus infections during the period
January 1, 2008 to December 31, 2012.
During this period, there were 3664 admission episodes for
infants and children with herpangina and HFMD. The laboratory
data including CRP level and total WBC count were available for
3566 out of 3664 episodes; thus 98 of 3664 episodes were
excluded from this study due to a lack of clinical and laboratory
information. Antibiotics were prescribed in 537 of the 3566
episodes (15%). Finally, a total of 214 episodes (6%) were enrolled
in group C on the basis of our criteria and were then evaluated
further in a demographic and descriptive study. Although group C
was the least populated group in our study, it had the highest
Table 1
Study children with enterovirus infection and a high CRP level (>80 mg/l):
demographic characteristics and clinical manifestations
Number of cases Proportion (%), or mean  SD
CRP, mg/l 214 122.92  28.33
WBC,  109/l 213 15.7  5.4
Age, years 214 2.43  1.87
Antibiotic therapy, no/yes 63/151 29.4/70.6
Herpangina/HFMD 148/64 69.2/29.9
Male/female 134/80 62.6/37.4
Septic workup, negative/positive
Blood culture 129/1 60.3/0.5
Urine culture 92/0 43/0
Stool culture 8/1 3.7/0.5
GAS testa 15/0 7.0/0
Virus isolation (throat swab) 20/13 9.3/6.1
CRP, C-reactive protein; WBC, white blood cell count; HFMD, hand, foot and mouth
disease; GAS, group A Streptococcus.
a GAS test: throat swab for group A streptococcal antigen and culture.
Table 2
Analysis of the case–control study for the comparison of demographic character-
istics and clinical manifestations in the subgroup with a high CRP level
Prescription of antibiotics p-Value
Yes
Case (n = 149)
No
Control (n = 62)
Age, years 2.38  1.70 2.60  2.27 0.452
Gender, male/female 93/56 38/24 0.878
CRP, mg/l 124.68  28.50 117.24  27.13 0.080
WBC,  109/l 16.27  5.54 14.67  4.84 0.050
Herpangina/HFMD 93/56 45/17 0.553
Septic workup Positive/negative Positive/negative
Blood culture 1/104 0/25 NA
Urine culture 0/64 0/28 NA
GAS testa 0/12 0/3 NA
Outcome
Total days of fever 2.93  1.06 2.98  0.98 0.713
Before admission 2.45  0.80 2.52  0.88 0.595
After admission 0.48  0.81 0.47  0.56 0.938
Length of hospital stay 4.02  1.40 3.34  1.50 0.020b
CRP, C-reactive protein; WBC, white blood cell count; HFMD, hand, foot and mouth
disease; GAS, group A Streptococcus; NA, not analysis.
a GAS test: throat swab for group A streptococcal antigen and culture.
b p < 0.05, statistically signiﬁcant difference.
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groups A (8.7%, 236/2701) and B (22.9%, 149/651) (Figure 1).
There was a signiﬁcant linear trend (p < 0.001) by Chi-square test
between these three groups. This ﬁnding may demonstrate that a
higher CRP level leads the clinician to prescribe antibiotics.
The characteristics of group C are further shown in Table 1.
Cases were distributed across all months of the year, except
January. The peak prevalences each year occurred in May–July and
October–November. Most patients were male (62.6%) and the
mean patient age was 2.48 years. Their mean  standard deviation
(SD) CRP level was 122.92  28.33 (range 80–277 mg/l) and total
WBC count was 15.7  5.4  109/l (range 6–34  109/l). Of the 214
cases, 148 (69.2%) had herpangina and 64 (29.9%) had HFMD. There
were no neurological complications or deaths in these cases. None
had a past history signiﬁcant for immune compromise or deﬁciency,
but one 3-year-old girl had an underlying disease (leukemia).
In group C, 151 cases had received antibiotic therapy for at least
24 h. The main indication for the antibiotic prescription in 105 of
these 151 cases (69.5%) was a suspected bacterial infection. Of the
remaining 46 cases, only nine had a speciﬁc antimicrobial
indication for a bacterial infectious disease, including seven cases
of acute otitis media (AOM) and two of sinusitis; however the
seven cases did not suffer from any obvious ear pain or prolonged
symptoms of respiratory tract infection, and according to their
medical records, no pneumatic otoscopy had ever been done. The
septic workup including blood culture, urine examination, and
group A Streptococcus (GAS) throat culture were all negative in
group C, except for one positive blood culture with Staphylococcus
haemolyticus, which was considered a contaminant following
repeat blood culture. Only one set of stool cultures showed
Salmonella, and infectious enteritis was diagnosed; no antibiotics
were prescribed for this case. Of a total 33 throat swabs for virus
isolation, only 13 revealed positive culture results, including ﬁve
cases of non-typeable enterovirus, two each of coxsackieviruses A2
and A6, and one each of coxsackieviruses A4, A5, A9, and A16. Of
these 13 patients with a positive virologic test, 12 received
antibiotic therapy during their hospitalization and only one did
not.
In the case–control study, clinical presentations and demo-
graphic characteristics were compared, as shown in Table 2.
Complete data were missing for three cases in group C, hence only
211 cases were enrolled in the case–control study. The distribu-
tions of age and gender in these two groups were not signiﬁcantly
different. The initial CRP level and WBC count were also not
signiﬁcantly different in the two groups. The outcome analysis
showed that the differences between these two groups in thenumber of febrile days before and after admission were not
statistically signiﬁcant. A comparison of the total number of
febrile days also showed no statistically signiﬁcant difference.
However, the case group (prescribed antibiotics) had a longer stay
in hospital than the control group (p = 0.020).
4. Discussion
We analyzed a total of 3566 episodes in pediatric inpatients
hospitalized over 5 years and found that antibiotics were
prescribed in 537 (15%) of them. In the present study, 6% of all
patients had a high CRP level (80 mg/l), which is consistent with
the data reported previously in the literature.5,6 However, a higher
proportion of antibiotic prescription was found in group C patients,
who had a high CRP level (71%), as compared to the other two
groups. Therefore, although we identiﬁed an elevation in CRP level
occurring in enterovirus infections both in the literature and from
our results, we found that the opportunity for antibiotic
prescription was still increased by a higher CRP level in our
study.1,5 This demonstrated that a higher CRP level leads to a
stronger tendency for clinicians to prescribe antibiotics for the care
of children with this type of infectious disease. The elevated CRP
levels made clinicians consider the possible existence of a
combined bacterial infection in these children.
In the literature, it has been noted that the indications for
prescribing antibiotics to patients with a high CRP level include a
suspected bacterial infection and AOM.1 Our study revealed that a
suspected bacterial infection was the most prominent reason for
the prescription of antibiotics as well. However, the evidence from
microbiological examinations was not strong enough to support a
deﬁnite bacterial infection, although the septic workup was not
complete for every case included in this study. We also found that
high CRP levels were not associated with neurological complica-
tions or death. Only nine cases were ﬁnally diagnosed with a
combined bacterial respiratory infection, such as AOM. Previous
research has revealed that AOM is often over-diagnosed in children
and needs further conﬁrmation.13–15 The disease AOM is a
complication of a viral upper respiratory tract infection in young
children. Therefore, patients should have experienced a runny nose
or nasal congestion for a few days before suffering from AOM.
However, the diagnosis of AOM in our cases may not be certain
because the patients did not have these clinical manifestations
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conﬁrmed by otolaryngologists. Such obscure diagnoses also
indicate that many pediatricians initially take the possibility of
a bacterial infection into account when facing this situation. They
may consider that antibiotic therapy will help these patients, but
do not have any exact or obvious evidence to conﬁrm this
hypothesis. In the future, more evidence will be needed and further
prospective studies are required.
In our case–control study, the results showed that antibiotic
therapy did not positively inﬂuence the outcome of the clinical
febrile course. The average duration of total febrile presentation in
both groups of patients was both approximately 3 days, which is
similar to the duration of the natural course of herpangina or
HFMD caused by an enterovirus infection. The CRP levels and total
WBC counts were not signiﬁcantly different in the statistical
analysis. Although the possibility of AOM could not exactly be
excluded in our study, our results suggest that most of the
antibiotic therapies prescribed were not appropriate, at least for
the indication of a suspected bacterial infection. On the other
hand, our ﬁndings revealed that patients given antibiotic therapy
had a signiﬁcantly longer stay in hospital than those patients who
were not given antibiotic therapy. It goes without saying that
longer periods of hospitalization increase medical costs consid-
erably.16 We assume that the duration of hospitalization mainly
depends on the clinical judgment of the treating physician. If the
clinician comes to the conclusion that their patient may be
suffering from a bacterial co-infection or sepsis, they may prefer to
keep the child in hospital for further management and observa-
tion. However, these cases did not have a longer febrile course and
all recovered without neurological sequelae or death. In our study,
a high CRP level was not associated with any serious enterovirus
complications, which is consistent with the ﬁndings of previous
research.5,17,18
Our study has limitations. The study design was retrospective
and all patients were from a single medical center; there may have
been some bias in the review of the medical records. Also the
prescription of antibiotics was dependent on the clinical judgment
of the treating physician. In the future we hope to perform
prospective studies to improve our understanding of this subject.
However, our results still provide an explanation of the proposal.
To the best of our knowledge and on the basis of the literature
review, this is the ﬁrst study to explore the implications of high CRP
levels and antibiotic prescription in enterovirus infections.
In conclusion, although previous studies have shown that
antibiotics are prescribed for some cases with a high CRP level, the
appropriateness of antibiotics has never been sufﬁciently explored.
According to our results, it may reasonably be concluded that
antibiotics are not beneﬁcial in the treatment of patients with
herpangina or HFMD with a high CRP level, especially due to a lack
of obvious evidence of bacterial co-infection. What is more,inappropriate antibiotic therapy may be associated with a longer
duration of hospitalization and increased medical costs.
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